• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗肾移植患者移植后糖尿病的发生率及危险因素

Frequency and risk factors for posttransplant diabetes mellitus in Iranian renal transplant patients.

作者信息

Ossareh S, Naseem S, Faraji M A, Bahrami Asl M, Yousefnejad A

机构信息

Department of Internal Medicine, Nephrology Ward, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Transplant Proc. 2009 Sep;41(7):2814-6. doi: 10.1016/j.transproceed.2009.07.054.

DOI:10.1016/j.transproceed.2009.07.054
PMID:19765443
Abstract

Posttransplant diabetes mellitus (PTDM) is a frequent complication of renal transplantation. This study was performed to determine the prevalence of and risk factors for PTDM among Iranian renal transplant recipients. In this cross-sectional study, 300 patients were studied in 2007. It included questionnaires with clinical data and blood samples. PTDM was defined as DM without a pretransplant history. The 184 (61.3%) male and 116 (38.7%) female patients of overall mean age of 41.2 +/- 13.5 years were 67.4 +/- 48.6 months after the procedure. PTDM was observed in 24 patients (8%). The mean interval to develop PTDM was 19.9 +/- 31.5 months. The mean age of PTDM patients was significantly higher than non-PTDM patients: 49.4 +/- 13.4 vs 40.6 +/- 13.4 years (P < .005). The mean serum high-density lipoprotein (HDL) was higher among PTDM compared with non-PTDM patients: 71.4 +/- 21 vs 58.6 +/- 14.6 (P < .005). There was a trend toward higher serum low-density lipoprotein (LDL) among PTDM patients: 109.2 +/- 29.5 vs 96.2 +/- 25.2 (P = .06). A recent admission was more frequent among PTDM patients (58.3% vs 28.7%; P < .005), as was history of hepatitis C virus (HCV) infection (6% vs 1%; P < .01). There was no significant difference in doses of immunosuppressive drugs and doses atenolol, mean body mass index, DM family history, rejection, cytomegalovirus (CMV) infection, or frequency of positive anti-HCV antibody between the 2 groups. Our study showed an 8% prevalence of PTDM. Mean age, history of recent admissions and HCV infection, as well as mean plasma HDL and LDL levels were higher among PTDM patients.

摘要

移植后糖尿病(PTDM)是肾移植常见的并发症。本研究旨在确定伊朗肾移植受者中PTDM的患病率及危险因素。在这项横断面研究中,2007年对300例患者进行了研究。研究内容包括临床数据问卷和血样采集。PTDM定义为移植前无糖尿病病史的糖尿病。184例(61.3%)男性和116例(38.7%)女性患者,总体平均年龄为41.2±13.5岁,术后67.4±48.6个月。24例患者(8%)出现PTDM。发生PTDM的平均间隔时间为19.9±31.5个月。PTDM患者的平均年龄显著高于非PTDM患者:49.4±13.4岁 vs 40.6±13.

相似文献

1
Frequency and risk factors for posttransplant diabetes mellitus in Iranian renal transplant patients.伊朗肾移植患者移植后糖尿病的发生率及危险因素
Transplant Proc. 2009 Sep;41(7):2814-6. doi: 10.1016/j.transproceed.2009.07.054.
2
Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients.肾移植受者移植后糖尿病的危险因素及预后
Transplant Proc. 2010 Jun;42(5):1685-9. doi: 10.1016/j.transproceed.2009.12.062.
3
Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.肾移植后新发糖尿病对常染色体显性多囊肾病患者移植肾功能的影响。
Ann Acad Med Stetin. 2008;54(1):41-8.
4
Posttransplant diabetes mellitus: incidence and risk factors.移植后糖尿病:发病率及危险因素
Transplant Proc. 2008 Apr;40(3):764-6. doi: 10.1016/j.transproceed.2008.03.018.
5
Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients.肾移植受者丙型肝炎病毒感染与移植后糖尿病发生之间的关联。
Transplantation. 2002 Oct 27;74(8):1109-13. doi: 10.1097/01.TP.0000031542.08424.85.
6
Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.肾移植受者早期移植后糖尿病的临床特征、他克莫司药代动力学及相关基因多态性的发生率和危险因素
Transplant Proc. 2005 May;37(4):1865-7. doi: 10.1016/j.transproceed.2005.02.086.
7
Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients.肾移植受者发生移植后糖尿病的危险因素。
Transplant Proc. 2006 Mar;38(2):529-32. doi: 10.1016/j.transproceed.2005.12.066.
8
Posttransplant diabetes mellitus: a single-center study.移植后糖尿病:一项单中心研究。
Transplant Proc. 2008 May;40(4):1111-3. doi: 10.1016/j.transproceed.2008.04.002.
9
Early hyperglycemia: a risk factor for posttransplant diabetes mellitus among renal transplant recipients.早期高血糖:肾移植受者移植后糖尿病的一个危险因素。
Transplant Proc. 2009 Jul-Aug;41(6):2664-7. doi: 10.1016/j.transproceed.2009.06.133.
10
Posttransplantation diabetes mellitus: prevalence and risk factors.移植后糖尿病:患病率及危险因素
Transplant Proc. 2005 Nov;37(9):3817-8. doi: 10.1016/j.transproceed.2005.09.197.

引用本文的文献

1
Association between ELMO1 gene polymorphisms and diabetic nephropathy in an Iranian population.伊朗人群中ELMO1基因多态性与糖尿病肾病的关联
J Diabetes Metab Disord. 2016 Oct 7;15:43. doi: 10.1186/s40200-016-0265-3. eCollection 2015.
2
Hyperglycemia after renal transplantation: frequency and risk factors.肾移植术后高血糖:发生率及危险因素
Nephrourol Mon. 2013 Spring;5(2):753-7. doi: 10.5812/numonthly.10773. Epub 2013 Mar 30.